EcoDrugPlus

60s Ribosomal Protein L10-Like

Ensembl ID : ENSLBEG00000016776
Gene Symbol: LOC110003015
3 Cross references
408 Possible Orthologues:

60s Ribosomal Protein L12

Ensembl ID : ENSLBEG00000004897
Gene Symbol: LOC109977546
3 Cross references
474 Possible Orthologues:

60s Ribosomal Protein L12-Like

Ensembl ID : ENSLBEG00000005393
Gene Symbol: LOC110001527
3 Cross references
474 Possible Orthologues:

60s Ribosomal Protein L12-Like

Ensembl ID : ENSLBEG00000007977
Gene Symbol: LOC109978024
3 Cross references
473 Possible Orthologues:

60s Ribosomal Protein L13a

Ensembl ID : ENSLBEG00000005434
Gene Symbol: LOC109990544
3 Cross references
290 Possible Orthologues:

60s Ribosomal Protein L19-Like

Ensembl ID : ENSLBEG00000010118
Gene Symbol: LOC109997578
3 Cross references
328 Possible Orthologues:

60s Ribosomal Protein L22-Like

Ensembl ID : ENSLBEG00000026618
Gene Symbol: LOC109983408
2 Cross references
198 Possible Orthologues:

60s Ribosomal Protein L26

Ensembl ID : ENSLBEG00000022531
Gene Symbol: LOC109994452
3 Cross references
477 Possible Orthologues:

60s Ribosomal Protein L3

Ensembl ID : ENSLBEG00000004376
Gene Symbol: LOC109998013
3 Cross references
335 Possible Orthologues:

60s Ribosomal Protein L37

Ensembl ID : ENSLBEG00000027894
Gene Symbol: LOC109998479
3 Cross references
423 Possible Orthologues:

60s Ribosomal Protein L37

Ensembl ID : ENSLBEG00000005693
Gene Symbol: LOC109976042
3 Cross references
423 Possible Orthologues:

60s Ribosomal Protein L5-A

Ensembl ID : ENSLBEG00000027893
Gene Symbol: LOC109982358
3 Cross references
455 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).